FFA
STOK icon

Farther Finance Advisors’s Stoke Therapeutics STOK Stock Holding History

Farther Finance Advisors’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$556 Sell
17
-23
-58% -$738 ﹤0.01% 5512
2026
Q1 		$1.28K Buy
40
+22
+122% +$721 ﹤0.01% 5036
2025
Q4 		$571 Buy
18
+1
+6% +$30 ﹤0.01% 5029
2025
Q3 		$400 Buy
17
+10
+143% +$171 ﹤0.01% 4593
2025
Q2 		$79 Hold
7
– – ﹤0.01% 4333
2025
Q1 		$44 Hold
7
– – ﹤0.01% 4135
2024
Q4 		$77 Hold
7
– – ﹤0.01% 3827
2024
Q3 		$86 Buy
+7
New +$99 ﹤0.01% 3806

Other funds holding STOK

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GIM
Generali Investments Management Ljubljana, Slovenia $460M AUM 29.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's STOK Position: Q2 2026 in Review

Farther Finance Advisors reduced its Stoke Therapeutics (STOK) stake by 58% in Q2 2026, selling an estimated $738 and leaving 17 shares worth $556. The position accounts for ﹤0.01% of the portfolio, ranked #5512.

Farther Finance Advisors first reported a position in STOK in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.28K in Q1 2026. 20 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Farther Finance Advisors held 17 shares of Stoke Therapeutics worth $556 as of Q2 2026.
  • Farther Finance Advisors sold 23 Stoke Therapeutics shares in Q2 2026, an estimated $738.
  • Stoke Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5512 holding.
  • Farther Finance Advisors first reported a position in Stoke Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Farther Finance Advisors's Stoke Therapeutics position peaked at $1.28K in Q1 2026.
  • 20 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.